Literature DB >> 9456122

"Incomplete resection" in non-small cell lung cancer: need for a new definition. Canadian Lung Oncology Group.

Y Lacasse1, H C Bucher, E Wong, L Griffith, S Walter, R J Ginsberg, G H Guyatt.   

Abstract

BACKGROUND: This study was designed to determine the prognostic value of positive surgical resection margin or highest nodal station sampled at thoracotomy in patients with non-small cell lung cancer.
METHODS: Two reviewers independently examined the surgical records and pathologic reports from a randomized trial comparing computed tomography versus mediastinoscopy for staging of lung cancer. They recorded pathologic findings at the surgical resection margin, the highest mediastinal nodal station sampled at thoracotomy, histologic type, tumor size, N status, and evidence of vascular or lymphatic invasion. These variables formed the independent variables in logistic regression models to predict recurrence.
RESULTS: Except for 1 patient, follow-up at 3 years for 399 included patients was complete. Significant predictors of recurrence were tumor size (odds ratio [OR], 1.2 (per centimeter); 99% CI [confidence interval], 1.1 to 1.4), and N status (compared with N0, N1: OR, 1.6; CI, 0.8 to 3.1; N2: OR, 3.2; CI, 1.4 to 7.5). Other variables, including positive surgical resection margin, did not predict early recurrence or death.
CONCLUSIONS: In patients with non-small cell lung cancer, surgical resection margin or highest nodal station sampled at thoracotomy that are involved by carcinoma do not predict recurrence. The current definition of incomplete resection has limited prognostic significance.

Entities:  

Mesh:

Year:  1998        PMID: 9456122     DOI: 10.1016/s0003-4975(97)01190-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Improving lung cancer outcomes by improving the quality of surgical care.

Authors:  Raymond U Osarogiagbon; Thomas A D'Amico
Journal:  Transl Lung Cancer Res       Date:  2015-08

2.  Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.

Authors:  G J M Herder; P Verboom; E F Smit; P C M van Velthoven; J H A M van den Bergh; C D Colder; I van Mansom; J C van Mourik; P E Postmus; G J J Teule; O S Hoekstra
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  [Application and interpretation of the R classification for lung cancer : Results of a survey of certified lung cancer centers].

Authors:  H Hoffmann; K Junker; C Kugler; P A Schnabel; A Warth
Journal:  Pathologe       Date:  2016-05       Impact factor: 1.011

4.  The prognostic impact of the mediastinal fat tissue invasion in patients with non-small cell lung cancer.

Authors:  Necati Çitak; Yunus Aksoy; Özgür İşgörücü; Ciğdem Obuz; Barış Açıkmeşe; Songül Büyükkale; Neslihan Akalın Fener; Muzaffer Metin; Adnan Sayar
Journal:  Gen Thorac Cardiovasc Surg       Date:  2020-07-16

5.  Adjuvant chemotherapy in resected lung cancer: two-year experience in a university hospital.

Authors:  Nichole Bouchard; Francis Laberge; Bruno Raby; Sylvie Martin; Yves Lacasse
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

6.  Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non-Small Cell Lung Cancer in the U.S. National Cancer Data Base.

Authors:  Raymond U Osarogiagbon; Chun Chieh Lin; Matthew P Smeltzer; Ahmedin Jemal
Journal:  J Thorac Oncol       Date:  2016-01       Impact factor: 15.609

7.  Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer.

Authors:  Meixiang Zhou; Tao Li; Yongmei Liu; Changjin Sun; Na Li; Yong Xu; Jiang Zhu; Zhenyu Ding; Yongsheng Wang; Meijuan Huang; Feng Peng; Jin Wang; Li Ren; You Lu; Youling Gong
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

8.  Complete spontaneous remission of small cell lung cancer in the absence of specific treatment: A case report.

Authors:  Sung Heon Song; Chang Won Ha; Changhwan Kim; Gil Myeong Seong
Journal:  Thorac Cancer       Date:  2021-08-20       Impact factor: 3.500

9.  The Prognosis According to Patterns of Mediastinal Lymph Node Metastasis in Pathologic Stage IIIA/N2 Non-Small Cell Lung Cancer.

Authors:  Do Wan Kim; Ju Sik Yun; Sang Yun Song; Kook Joo Na
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.